Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
Case Analysis on Real Life Incidence of PDT Safety Outcomes: Multicentre, Observational Post-marketing Safety Surveillance Registry of Patients Exposed to Photodynamic Therapy With Porfimer Sodium: The CALIPSO Registry
Status: Archived
Ohio State University
mi
from
Columbus, OH
Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes
Case Analysis on Real Life Incidence of PDT Safety Outcomes: Multicentre, Observational Post-marketing Safety Surveillance Registry of Patients Exposed to Photodynamic Therapy With Porfimer Sodium: The CALIPSO Registry
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Burn treatment center
mi
from
Iowa City, IA
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Updated: 1/1/1970
Burn treatment center
mi
from
Iowa City, IA
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Center for Curative & Palliative Wound Care Calvary Hospital
mi
from
New York, NY
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
Status: Archived
Updated: 1/1/1970
Center for Curative & Palliative Wound Care Calvary Hospital
mi
from
New York, NY
Split Thickness Donor Site Pilot Study
A Prospective, Randomized, Controlled Pilot Study of the MIST Therapy System for the Treatment of Split Thickness Donor Sites
Status: Archived
James A. Haley VA Hospital
mi
from
Tampa, FL
Split Thickness Donor Site Pilot Study
A Prospective, Randomized, Controlled Pilot Study of the MIST Therapy System for the Treatment of Split Thickness Donor Sites
Status: Archived
Updated: 1/1/1970
James A. Haley VA Hospital
mi
from
Tampa, FL
Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
A Phase II, Randomized, Single Dose, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety Profile of the CollaRx® Bupivacaine Implant (200 mg Bupivacaine Hydrochloride) in Men After Open Laparotomy Herniorrhaphy
Status: Archived
Clinical Trial Facility
mi
from
Austin, TX
Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy
A Phase II, Randomized, Single Dose, Double-blind, Placebo Controlled Study to Investigate the Efficacy and Safety Profile of the CollaRx® Bupivacaine Implant (200 mg Bupivacaine Hydrochloride) in Men After Open Laparotomy Herniorrhaphy
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Austin, TX
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
Status: Archived
Charles River Clinical Services
mi
from
Tacoma, WA
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects
Status: Archived
Updated: 1/1/1970
Charles River Clinical Services
mi
from
Tacoma, WA
A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function
An Open-label, Single-center Study to Assess the Pharmacokinetics of R406 in Subjects With Hepatic Impairment and in Healthy Subjects Following Administration of a Single Dose of Fostamatinib Disodium 150 mg
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study of Fostamatinib in Subjects With Impaired Hepatic (Liver) Function
An Open-label, Single-center Study to Assess the Pharmacokinetics of R406 in Subjects With Hepatic Impairment and in Healthy Subjects Following Administration of a Single Dose of Fostamatinib Disodium 150 mg
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Metronidazole Pharmacokinetics (PK) in Premature Infants
Safety and Pharmacokinetics of Multiple Dose Metronidazole in Premature Infants
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Metronidazole Pharmacokinetics (PK) in Premature Infants
Safety and Pharmacokinetics of Multiple Dose Metronidazole in Premature Infants
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant in Men After Laparoscopic Inguinal or Umbilical Herniorrhaphy
A Phase II, Single-dose, Open-label Study to Investigate the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant (200 mg Bupivacaine Hydrochloride) in Men After Laparoscopic Inguinal or Umbilical Herniorrhaphy
Status: Archived
Research Concepts
mi
from
Bellaire, TX
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant in Men After Laparoscopic Inguinal or Umbilical Herniorrhaphy
A Phase II, Single-dose, Open-label Study to Investigate the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant (200 mg Bupivacaine Hydrochloride) in Men After Laparoscopic Inguinal or Umbilical Herniorrhaphy
Status: Archived
Updated: 1/1/1970
Research Concepts
mi
from
Bellaire, TX
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology of the Rockies
mi
from
Lafayette, CO
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology of the Rockies
mi
from
Lafayette, CO
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Center of Connecticut P.C.
mi
from
Hamden, CT
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Center of Connecticut P.C.
mi
from
Hamden, CT
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Associates
mi
from
Baton Rouge, LA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Associates
mi
from
Baton Rouge, LA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Research of New Orleans
mi
from
Hammond, LA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Metropolitan Gastroenterology Group, P.C.
mi
from
Chevy Chase, MD
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Center for Digestive Health
mi
from
Troy, MI
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Center for Digestive Health
mi
from
Troy, MI
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Long Island Clinical Research Associates
mi
from
Great Neck, NY
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Charlotte Gastroenterology and Hepatology
mi
from
Charlotte, NC
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Options Health Research
mi
from
Tulsa, OK
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Options Health Research
mi
from
Tulsa, OK
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
The Oregon Clinic - Pulmonary and Critical Care Medicine
mi
from
Portland, OR
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
The Oregon Clinic - Pulmonary and Critical Care Medicine
mi
from
Portland, OR
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Consultants in Gastroenterology
mi
from
Columbia, SC
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Consultants in Gastroenterology
mi
from
Columbia, SC
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Center of the MidSouth, PC
mi
from
Germantown, TN
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Center of the MidSouth, PC
mi
from
Germantown, TN
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Gastroenterology Clinic of San Antonio
mi
from
San Antonio, TX
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Gastroenterology Clinic of San Antonio
mi
from
San Antonio, TX
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Digestive Health Research Unit
mi
from
Scottsdale, AZ
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Digestive Health Research Unit
mi
from
Scottsdale, AZ
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
University of Washington
mi
from
Seattle, WA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
University of Washington
mi
from
Seattle, WA
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction of Clinical Response and Remission by Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Status: Archived
Updated: 1/1/1970
Wisconsin Center for Advanced Research
mi
from
Milwaukee, WI
GSK1349572 Hepatic Impairment Study
A Phase I, Open-Label, Parallel-Group, Two-Part, Adaptive Study to Evaluate the Pharmacokinetics and Safety of GSK1349572 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (ING113097)
Status: Archived
Georgetown Univ Med Ctr
mi
from
Washington,
GSK1349572 Hepatic Impairment Study
A Phase I, Open-Label, Parallel-Group, Two-Part, Adaptive Study to Evaluate the Pharmacokinetics and Safety of GSK1349572 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects (ING113097)
Status: Archived
Updated: 1/1/1970
Georgetown Univ Med Ctr
mi
from
Washington,
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
The Atopic Dermatitis Clinic as an Entry Point for Community Outreach in Asthma, Missed Immunizations, and Vitamin D Deficiency
Status: Archived
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Asthma, Missed Immunizations, and Vitamin D Deficiency in Atopic Dermatitis
The Atopic Dermatitis Clinic as an Entry Point for Community Outreach in Asthma, Missed Immunizations, and Vitamin D Deficiency
Status: Archived
Updated: 1/1/1970
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Vitamin D, Diet and Activity Study
Vitamin D, Weight Loss, and Breast Cancer Biomarkers
Status: Archived
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Vitamin D, Diet and Activity Study
Vitamin D, Weight Loss, and Breast Cancer Biomarkers
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Vitamin D Supplementation in Breastfeeding Women
Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum
Status: Archived
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Vitamin D Supplementation in Breastfeeding Women
Maternal Oral Vitamin D Supplementation Via Daily or Monthly Regimens and the Effect on Levels of Vitamin D in Human Milk and Infant Serum
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
mi
from
Rochester, MN
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
A Randomized Phase III Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Status: Archived
Cleveland Clinic Florida
mi
from
Weston, FL
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
A Randomized Phase III Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
[13C]-Spirulina Platensis GEBT
[13C]-Spirulina Platensis GEBT - Dual-Label Validation Study
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
[13C]-Spirulina Platensis GEBT
[13C]-Spirulina Platensis GEBT - Dual-Label Validation Study
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Vitamin D in HIV-Infected Patients on HAART
Vitamin D, Immune Activation, and Metabolic Abnormalities in HIV-Infected Patients on Antiretroviral Therapy
Status: Archived
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic
mi
from
Los Angeles, CA
Vitamin D in HIV-Infected Patients on HAART
Vitamin D, Immune Activation, and Metabolic Abnormalities in HIV-Infected Patients on Antiretroviral Therapy
Status: Archived
Updated: 1/1/1970
UCLA Center for Clinical AIDS Research and Education (CARE) Clinic
mi
from
Los Angeles, CA
Ketones & Mitochondrial Heteroplasmy
Ketones & Mitochondrial Heteroplasmy
Status: Archived
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Ketones & Mitochondrial Heteroplasmy
Ketones & Mitochondrial Heteroplasmy
Status: Archived
Updated: 1/1/1970
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Kristalose as Bowel Evacuant Prior to Colonoscopy
A Single Center, Open-Label, Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Kristalose as a Bowel Evacuant Prior to Colonoscopy
Status: Archived
Virginia Mason Medical Center
mi
from
Seattle, WA
Kristalose as Bowel Evacuant Prior to Colonoscopy
A Single Center, Open-Label, Pilot Study to Determine the Safety, Efficacy, and Patient Preference of Kristalose as a Bowel Evacuant Prior to Colonoscopy
Status: Archived
Updated: 1/1/1970
Virginia Mason Medical Center
mi
from
Seattle, WA
Early Detection of Barrett's Esophagus
Barrett's Esophagus Early Detection Study
Status: Enrolling
Updated:  12/31/1969
National Naval Medical Center
mi
from
Bethesda, MD
Early Detection of Barrett's Esophagus
Barrett's Esophagus Early Detection Study
Status: Enrolling
Updated: 12/31/1969
National Naval Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Efficacy of Voice Treatment for Parkinson's Disease
Efficacy of Voice Treatment for Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
National Center for Voice and Speech-Denver; An Affiliate of the unniversity of Colorado
mi
from
Denver, CO
Efficacy of Voice Treatment for Parkinson's Disease
Efficacy of Voice Treatment for Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
National Center for Voice and Speech-Denver; An Affiliate of the unniversity of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy of Voice Treatment for Parkinson's Disease
Efficacy of Voice Treatment for Parkinson's Disease
Status: Enrolling
Updated:  12/31/1969
University of Texas HSC San Antonio
mi
from
San Antonio, TX
Efficacy of Voice Treatment for Parkinson's Disease
Efficacy of Voice Treatment for Parkinson's Disease
Status: Enrolling
Updated: 12/31/1969
University of Texas HSC San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Analysis of Lyme Disease Lesions
Analysis of Erythema Migrans Lesions
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Analysis of Lyme Disease Lesions
Analysis of Erythema Migrans Lesions
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
Baylor University
mi
from
Dallas, TX
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Baylor University
mi
from
Dallas, TX
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Denver, CO
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials